home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Mismatch Associated with Graft-Versus-Host-Disease

 
  December, 11 2009 9:31
your information resource in human molecular genetics
 
     

A genetic mismatch involving the gene UGT2B17 is associated with risk of acute graft-versus-host-disease, according to a study published online in Nature Genetics.

Graft-versus-host-disease (GVHD) is a common complication after bone marrow transplant and is caused by an immune response mounted by the donor-derived cells against the host's body. GVHD occurs in 30-40% of transplants between related donors and recipients and up to 60-80% of transplants between unrelated donors and recipients.

Steven McCarroll and colleagues analyzed gene deletions in over 1000 sibling donor-recipient pairs and found a greater risk of acute GVHD in pairs where the donor had deletions in both copies of the gene UGT2B17 and the recipient did not have these deletions. The risk effect of UGT2B17 mismatch is comparable to the established risk effect of gender mismatch -- such as female donor and male recipient.

Author contact:

Steven McCarroll (Broad Institute of Harvard and MIT, Cambridge, MA, USA)
E-mail: smccarro@broad.mit.edu

Abstract available online.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.